These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23089529)

  • 41. High-dose bolus tirofiban versus low-dose bolus in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Ulus T; Şenol U; Tahmazov S; Iskenderov K; Mutlu F; Çavuşoğlu Y
    Turk Kardiyol Dern Ars; 2017 Mar; 45(2):126-133. PubMed ID: 28424434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of 5 Prognostic Scores for Prediction of Stroke, Thromboembolic and Coronary Events, All-Cause Mortality, and Major Adverse Cardiac Events in Patients With Atrial Fibrillation and Coronary Stenting.
    Fauchier L; Lecoq C; Ancedy Y; Stamboul K; Saint Etienne C; Ivanes F; Angoulvant D; Babuty D; Cottin Y; Lip GY
    Am J Cardiol; 2016 Sep; 118(5):700-7. PubMed ID: 27453515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antithrombotic treatment in patients with acute coronary syndromes and atrial fibrillation. What is established and what is missing.
    Tsioufis C
    Hellenic J Cardiol; 2018; 59(1):66-67. PubMed ID: 29704565
    [No Abstract]   [Full Text] [Related]  

  • 44. [CLINICAL PERSPECTIVES OF COMPLEX APPLICATION OF PERCUTANEOUS CORONARY INTERVENTION AND DRUG REVASCULARIZATION IN ACUTE CORONARY SYNDROME].
    Agayev MM
    Lik Sprava; 2014; (9-10):46-56. PubMed ID: 26492775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    Kang DO; Yu CW; Kim HD; Cho JY; Joo HJ; Choi RK; Park JS; Lee HJ; Kim JS; Park JH; Hong SJ; Lim DS
    Coron Artery Dis; 2015 Aug; 26(5):372-80. PubMed ID: 25768244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Suggested strategies tailored to an integrated evaluation of different risk profiles.
    Patti G; Rubboli A
    Eur J Intern Med; 2017 Jun; 41():e10-e11. PubMed ID: 28365223
    [No Abstract]   [Full Text] [Related]  

  • 47. Rationale and design of MANJUSRI trial: a randomized, open-label, active-controlled multicenter study to evaluate the safety of combined therapy with ticagrelor and warfarin in AF subjects after PCI-eS.
    Lu W; Chen L; Wang Y; Yao Y; Fu C; Zuo P; Ma G
    Contemp Clin Trials; 2015 Jan; 40():166-71. PubMed ID: 25513965
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and efficacy of first-generation and second-generation drug-eluting stents in the setting of acute coronary syndromes.
    Gorla R; Loffi M; Verna E; Margonato A; Salerno-Uriarte J
    J Cardiovasc Med (Hagerstown); 2014 Jul; 15(7):532-42. PubMed ID: 24922044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combinations of antithrombotic therapies prescribed after percutaneous coronary intervention in patients with acute coronary syndromes and atrial fibrillation: data from the nationwide MATADOR-PCI registry.
    De Luca L; Bolognese L; Rubboli A; Vetrano A; Callerame M; Rivetti L; Gonzini L; Gabrielli D; Di Lenarda A; Gulizia MM;
    Eur Heart J Cardiovasc Pharmacother; 2021 May; 7(3):e45-e47. PubMed ID: 32651996
    [No Abstract]   [Full Text] [Related]  

  • 50. Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies.
    Bavishi C; Koulova A; Bangalore S; Sawant A; Chatterjee S; Ather S; Valencia J; Sarafoff N; Rubboli A; Airaksinen JK; Lip GY; Tamis-Holland JE
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):E12-22. PubMed ID: 26354765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stenting.
    Pipilis A; Lazaros G; Tsakonas G; Stefanadis C
    Hellenic J Cardiol; 2010; 51(4):330-7. PubMed ID: 20650831
    [No Abstract]   [Full Text] [Related]  

  • 52. Antithrombotic Therapy to Reduce Ischemic Events in Acute Coronary Syndromes Patients Undergoing Percutaneous Coronary Intervention.
    Verheugt FW
    Interv Cardiol Clin; 2017 Jan; 6(1):131-140. PubMed ID: 27886817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. OPTIMUM APPLICATION OF MODERN ANTITHROMBOTIC DRUGS AMONG PATIENTS WITH THE ACUTE CORONARY SYNDROME WITH THE RISK OF STRICTURE FORMATION OF CORONARY ARTERIES.
    Zhunussov Y; Taizhanova D; Abdullabekova R; Bitz U; Visternichan O
    Georgian Med News; 2016 Feb; (251):40-5. PubMed ID: 27001784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atrial fibrillation: stroke prevention in older adults.
    Quinn GR; Fang MC
    Clin Geriatr Med; 2012 Nov; 28(4):617-34. PubMed ID: 23101573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antithrombotic therapy: triple therapy or triple threat?
    Mega J; Carreras ET
    Hematology Am Soc Hematol Educ Program; 2012; 2012():547-52. PubMed ID: 23233633
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term safety and efficacy of second-generation everolimus-eluting stents compared to other limus-eluting stents and bare metal stents in patients with acute coronary syndrome.
    Omar A; Torguson R; Kitabata H; Pendyala LK; Loh JP; Magalhaes MA; Satler LF; Suddath WO; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1053-60. PubMed ID: 24619969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of ischaemic heart disease in haemophilia patients: an institutional guideline.
    Schutgens RE; Tuinenburg A; Roosendaal G; Guyomi SH; Mauser-Bunschoten EP
    Haemophilia; 2009 Jul; 15(4):952-8. PubMed ID: 19473421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antithrombotic therapy in patients with combined coronary heart disease and atrial fibrillation.
    Thompson PL; Morton AC
    Panminerva Med; 2016 Mar; 58(1):23-33. PubMed ID: 26658287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey.
    Potpara TS; Lip GY; Dagres N; Estner HL; Larsen TB; Blomström-Lundqvist C;
    Europace; 2014 Feb; 16(2):293-8. PubMed ID: 24478291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coronary intervention: radial artery access comes of age.
    Jolly SS; Mehta SR
    Lancet; 2015 Jun; 385(9986):2437-9. PubMed ID: 25791213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.